ArticleBMC health services research2026
The cost of heart failure in Australia: a linked primary and secondary care analysis.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeart failure (HF) places a substantial and rising burden on Australia's health system. Existing cost estimates are outdated and based on modelling rather than real-world data. This study provides an updated estimate using linked healthcare records.
methodsThis study used linked general practice, hospital, emergency, and mortality data from Western Australia. Individuals with HF were matched 1:1 to controls on age, sex, diabetes, and ischaemic heart disease. Direct healthcare costs for 2021 were calculated from the government payer perspective and expressed in 2024 AUD. Attributable costs were estimated using matched comparisons and regression modelling.
resultsThe mean attributable cost to heart failure was $10,878 per person-year. Hospitalisations accounted for 79% of total costs. Costs were higher in those with comorbidities and during the first two years post-diagnosis. Nationally, total direct HF costs were estimated at approximately $6.3-6.6 billion per year.
conclusionHF places a substantial and preventable strain on the healthcare system, with hospitalisations the main cost driver. Scaling up evidence-based ambulatory models, such as nurse-led care, virtual wards, and remote monitoring, offers a high-value opportunity to improve outcomes and reduce unnecessary admission. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.